SaranyaKodaliMD

Physician

Dr. Kodali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2130 NE Loop 410 Ste 100
San Antonio, TX 78217
Phone+1 210-656-7177

Fax+1 210-656-3687

University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2019
UMass Chan Medical SchoolResidency, Internal Medicine, 2013 - 2016
Mahatma Gandhi Institute of Medical ScienceClass of 2011

PubMed

24 citations
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
Robert F. Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie S. Callander
American Journal of Hematology. 2021-01-01
416 citations
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman, Zhubin Gahvari, Elizabeth McGehee
Leukemia. 2019-09-01
5 citations
Successful management of refractory bleeding in liver failure with tranexamic acid: Case report and literature review.
Saranya Kodali, Chris E. Holmes, Eswar Tipirneni, Christina R. Cahill, Andrew J. Goodwin
Research and Practice in Thrombosis and Haemostasis. 2019-04-26

Lectures

Utility of the Breast Cancer Index (BCI) in the clinical practice.
2019 ASCO Annual Meeting - 6/1/2019
Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Introducing Saranya Chowdary Kodali to Texas Oncology–San Antonio NortheastOctober 10th, 2024
Eswar Tipirneni, MD, Joins UVM Health Network – Central Vermont Medical Center Cancer TeamDecember 29th, 2015